1. False-positive Aspergillus galactomannan immunoassays associated with intravenous human immunoglobulin administration. (November 2020) Authors: Liu, W.-D.; Lin, S.-W.; Shih, M.-C.; Su, C.-L.; Wang, Y.-W.; Lin, S.-C.; Lee, Y.-F.; Huang, H.-H.; Chou, W.-C.; Wu, U.-I.; Chen, Y.-C.; Chang, S.-C. Journal: Clinical microbiology and infection Issue: Volume 26:Number 11(2020) Page Start: 1555.e9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. S131: CLINICAL IMPLICATIONS OF SECONDARY-AML TYPE MUTATIONS IN PATIENTS WITH DE NOVO ACUTE MYELOID LEUKEMIA. (23rd June 2022) Authors: Sun, K.; Tsai, C.-H.; Lo, M.-Y.; Tseng, M.-H.; Kuo, Y.-Y.; Liu, M.-C.; Lin, C.-C.; Cheng, C.-L.; Wu, S.-J.; Chen, C.-Y.; Ko, B.-S.; Yao, M.; Chou, W.-C.; Hou, H.-A.; Tien, H.-F. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. S216: CLINICAL ACTIVITY OF CC-99282, A CEREBLON E3 LIGASE MODULATOR (CELMOD) AGENT, IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA (R/R NHL) – RESULTS FROM A PHASE 1, OPEN-LABEL STUDY. (23rd June 2022) Authors: Michot, J.-M.; Chavez, J. C.; Carpio, C; Ferrari, S.; Feldman, T. A.; Morillo, D.; Kuruvilla, J.; Pinto, A.; Ribrag, V.; Bachy, E; Buchholz, T. J.; Carrancio, S.; Chou, W.-C.; Guarinos, C.; Wu, F.; Li, S.; Patah, P.; Pourdehnad, M.; Nastoupil, L. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 117 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗